Announcements Trials

Browse Landscape

Phase

Phase 2 13 Phase 3 4 Phase 1/2 3 Phase 1 2 Phase EARLY_PHASE1 1

Status

Active not recruiting 2 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 97 Prostatic Neoplasms 41 Neoplasms 40 Glioblastoma 26 Melanoma 24 Head and Neck Neoplasms 24 Brain Neoplasms 24 Ovarian Neoplasms 18 Squamous Cell Carcinoma of Head and Neck 17 Lung Neoplasms 17 Carcinoma, Renal Cell 17 Carcinoma, Hepatocellular 17 Glioma 16 Pancreatic Neoplasms 15 Carcinoma, Non-Small-Cell Lung 15 Leukemia, Myeloid, Acute 14 Colorectal Neoplasms 14 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Urinary Bladder Neoplasms 10 Lymphoma 10 Uterine Cervical Neoplasms 9 Polycystic Ovary Syndrome 9 Lymphoma, Non-Hodgkin 9 Fallopian Tube Neoplasms 9 Endometrial Neoplasms 9 Myelodysplastic Syndromes 8 Multiple Myeloma 8 Lymphoma, Mantle-Cell 8 Lymphoma, Large B-Cell, Diffuse 8 Skin Neoplasms 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Completed × Sarcoma, Alveolar Soft Part × Clear all

NCT06827886 2025-07-23

GCAR1

AHS Cancer Control Alberta

Phase EARLY_PHASE1 Completed

Sarcoma, Alveolar Soft Part

Data powered by HemOnc (CC BY 4.0) Colophon ⚡